A股異動丨雲天化(600096.SH)漲超6% 月內累計反彈30%
格隆匯2月22日丨雲天化(600096.SH)逆勢漲超6%,月內累計漲幅達30%。現報22.31元,大幅成交33.88億元,總市值409億元。國海證券日前表示,雲天化主要產品仍處於高景氣週期,且估值仍處於較低水平,維持“買入”評級。受益於產品價格上漲,公司2021年業績實現高速增長。進入2022年,公司主要產品價格延續了高位震盪的格局。另外,2月17日,公司與雲南省玉溪市人民政府、億緯鋰能等簽訂新能源電池全產業鏈項目合作協議。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.